Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Curr Opin Rheumatol

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    November 2022
  1. KINGSMORE KM, Lipsky PE
    Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus.
    Curr Opin Rheumatol. 2022;34:374-381.
    PubMed     Abstract available


    September 2022
  2. LORENTZON M, Abrahamsen B
    Osteoporosis epidemiology using international cohorts.
    Curr Opin Rheumatol. 2022;34:280-288.
    PubMed     Abstract available


    July 2022
  3. IZNARDO H, Puig L
    Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes.
    Curr Opin Rheumatol. 2022;34:225-234.
    PubMed     Abstract available


    May 2022
  4. LUIS M, Boers M, Saag K, Buttgereit F, et al
    The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence.
    Curr Opin Rheumatol. 2022;34:179-186.
    PubMed     Abstract available


    March 2022
  5. ANASTASIOU C, Yazdany J
    Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
    Curr Opin Rheumatol. 2022;34:95-102.
    PubMed     Abstract available


    November 2021
  6. BIRRU TALABI M, Himes KP, Clowse MEB
    Optimizing reproductive health management in lupus and Sjogren's syndrome.
    Curr Opin Rheumatol. 2021;33:570-578.
    PubMed     Abstract available


    September 2021
  7. SATTUI SE, Crow MK, Navarro-Millan I
    The role of immunomodulatory medications in the treatment of COVID-19.
    Curr Opin Rheumatol. 2021;33:431-445.
    PubMed     Abstract available


  8. RANDELL RL, Becker ML
    Safety updates in novel therapeutics for pediatric rheumatic disease.
    Curr Opin Rheumatol. 2021;33:403-408.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: